{
  "source_file": "1 Psychopharmacology \u2013 Antipsychotics and Antidepressants.md",
  "domain": "1 Biological Bases of Behavior",
  "questions": [
    {
      "id": "PHARMA_001",
      "difficulty": "easy",
      "type": "basic",
      "question": "What are antipsychotics used to treat?",
      "options": {
        "A": "Anxiety and panic disorders",
        "B": "Schizophrenia and psychotic disorders",
        "C": "Depression and mood disorders",
        "D": "Insomnia and sleep disorders"
      },
      "correct_answer": "B",
      "kn_id": "KN3",
      "explanation": "Antipsychotics (neuroleptics) are used to treat schizophrenia and other disorders with psychotic symptoms, with first-generation drugs being more effective for positive than negative symptoms."
    },
    {
      "id": "PHARMA_002",
      "difficulty": "medium",
      "type": "basic",
      "question": "How do first-generation antipsychotics exert their therapeutic effects?",
      "options": {
        "A": "Block serotonin receptors",
        "B": "Block dopamine D2 receptors",
        "C": "Increase acetylcholine levels",
        "D": "Inhibit norepinephrine reuptake"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "First-generation antipsychotics are dopamine antagonists that exert therapeutic effects primarily by blocking dopamine (D2) receptors."
    },
    {
      "id": "PHARMA_003",
      "difficulty": "medium",
      "type": "basic",
      "question": "Which side effects are most common with low potency first-generation antipsychotics?",
      "options": {
        "A": "Extrapyramidal effects",
        "B": "Anticholinergic effects",
        "C": "Hypertensive crisis",
        "D": "Seizure activity"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Low potency first-generation antipsychotics (chlorpromazine, thioridazine) cause anticholinergic effects like dry mouth, urinary retention, and blurred vision."
    },
    {
      "id": "PHARMA_004",
      "difficulty": "medium",
      "type": "basic",
      "question": "What is tardive dyskinesia and when does it appear?",
      "options": {
        "A": "Muscle tremor appearing within days",
        "B": "Involuntary movements from long-term use",
        "C": "Temporary akinesia during treatment",
        "D": "Heart palpitations from medication"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Tardive dyskinesia is a potentially irreversible extrapyramidal effect involving involuntary tongue and facial movements that begins after long-term drug use and is more common in women and older adults."
    },
    {
      "id": "PHARMA_005",
      "difficulty": "hard",
      "type": "difficult",
      "question": "What is neuroleptic malignant syndrome and how is it managed?",
      "options": {
        "A": "Common side effect requiring dose increase",
        "B": "Rare life-threatening condition requiring drug cessation",
        "C": "Temporary akathisia resolved by switching drugs",
        "D": "Metabolic complication managed with diet"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Neuroleptic malignant syndrome is a rare, life-threatening side effect involving muscle rigidity, high fever, and autonomic dysfunction; managed by stopping the drug immediately and providing supportive care."
    },
    {
      "id": "PHARMA_006",
      "difficulty": "medium",
      "type": "basic",
      "question": "How do second-generation antipsychotics differ from first-generation drugs?",
      "options": {
        "A": "Less effective for positive symptoms",
        "B": "Dopamine antagonists only; no serotonin effects",
        "C": "Both dopamine and serotonin antagonists",
        "D": "Exclusively for treatment-resistant cases"
      },
      "correct_answer": "C",
      "kn_id": "KN2",
      "explanation": "Second-generation antipsychotics are dopamine-serotonin antagonists that are as or more effective than first-generation drugs and may reduce negative symptoms by blocking 5-HT2A receptors."
    },
    {
      "id": "PHARMA_007",
      "difficulty": "hard",
      "type": "difficult",
      "question": "What is agranulocytosis and which antipsychotic requires blood monitoring?",
      "options": {
        "A": "Weight gain; requires metabolic monitoring",
        "B": "Dangerously low white blood cells; clozapine",
        "C": "Tremor and muscle rigidity; haloperidol",
        "D": "Heart rhythm changes; requires EKG"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Agranulocytosis is a potentially life-threatening condition involving dangerously low neutrophil levels; clozapine requires regular blood tests to monitor for this and other hematologic side effects."
    },
    {
      "id": "PHARMA_008",
      "difficulty": "medium",
      "type": "basic",
      "question": "What mechanism do third-generation antipsychotics use?",
      "options": {
        "A": "Pure dopamine antagonism",
        "B": "Pure serotonin antagonism",
        "C": "Dopamine-serotonin stabilizers",
        "D": "GABA enhancement"
      },
      "correct_answer": "C",
      "kn_id": "KN2",
      "explanation": "Third-generation antipsychotics are dopamine-serotonin stabilizers with both antagonist and partial agonist effects, allowing them to reduce dopamine where high and raise it where low."
    },
    {
      "id": "PHARMA_009",
      "difficulty": "easy",
      "type": "basic",
      "question": "Which antidepressants are considered first-line treatment?",
      "options": {
        "A": "TCAs and MAOIs",
        "B": "Selective serotonin reuptake inhibitors",
        "C": "Stimulants like methylphenidate",
        "D": "Barbiturates and benzodiazepines"
      },
      "correct_answer": "B",
      "kn_id": "KN3",
      "explanation": "SSRIs (fluoxetine, sertraline, paroxetine) are the most frequently prescribed antidepressants and are generally first-line treatment for major depressive and persistent depressive disorders."
    },
    {
      "id": "PHARMA_010",
      "difficulty": "medium",
      "type": "basic",
      "question": "How do SSRIs exert their antidepressant effects?",
      "options": {
        "A": "Inhibit monoamine oxidase enzyme",
        "B": "Block serotonin reuptake presynaptically",
        "C": "Increase dopamine and norepinephrine",
        "D": "Enhance GABA transmission"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "SSRIs are indirect agonists that increase serotonin availability by blocking its reuptake by presynaptic neurons, allowing greater availability at postsynaptic receptors."
    },
    {
      "id": "PHARMA_011",
      "difficulty": "hard",
      "type": "difficult",
      "question": "What is serotonin syndrome and when does it occur?",
      "options": {
        "A": "Gradual reduction of SSRI effectiveness",
        "B": "Potentially fatal toxicity from excessive serotonin",
        "C": "Withdrawal symptoms from abrupt cessation",
        "D": "Long-term sexual dysfunction side effect"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Serotonin syndrome is a potentially fatal condition occurring when SSRIs combine with MAOIs or other serotonergic drugs, causing extreme agitation, autonomic instability, hyperthermia, and seizures."
    },
    {
      "id": "PHARMA_012",
      "difficulty": "medium",
      "type": "distinction",
      "question": "How do SSRIs and SNRIs differ in their mechanism?",
      "options": {
        "A": "SSRIs block dopamine; SNRIs block serotonin",
        "B": "SSRIs affect serotonin only; SNRIs also affect norepinephrine",
        "C": "SNRIs have fewer side effects",
        "D": "SSRIs are first-line; SNRIs are second-line"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "SSRIs selectively block serotonin reuptake, while SNRIs block both serotonin and norepinephrine reuptake; SNRIs may be more effective for severe depression."
    },
    {
      "id": "PHARMA_013",
      "difficulty": "medium",
      "type": "basic",
      "question": "What unique side effect distinguishes bupropion from other antidepressants?",
      "options": {
        "A": "Causes significant sexual dysfunction",
        "B": "Causes seizures at therapeutic doses",
        "C": "Does not cause sexual dysfunction",
        "D": "Causes severe anticholinergic effects"
      },
      "correct_answer": "C",
      "kn_id": "KN2",
      "explanation": "Bupropion (an NDRI) has advantages of causing few anticholinergic effects, no sexual dysfunction, and not being cardiotoxic, making it useful for patients with these concerns."
    },
    {
      "id": "PHARMA_014",
      "difficulty": "medium",
      "type": "basic",
      "question": "Which antidepressant class poses the greatest cardiac toxicity risk?",
      "options": {
        "A": "SSRIs and SNRIs",
        "B": "Tricyclic antidepressants",
        "C": "Bupropion (NDRIs)",
        "D": "MAOIs only"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "TCAs are cardiotoxic and lethal in overdose, requiring cautious prescription for patients with heart disease or suicidal ideation; secondary amines have fewer cardiovascular side effects than tertiary amines."
    },
    {
      "id": "PHARMA_015",
      "difficulty": "hard",
      "type": "difficult",
      "question": "What is tachyphylaxis and how is it managed?",
      "options": {
        "A": "Rapid heart rate from medication",
        "B": "Loss of antidepressant response over time",
        "C": "Withdrawal symptoms upon discontinuation",
        "D": "Tolerance developed to side effects"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Tachyphylaxis (antidepressant poop-out) is loss of previously effective antidepressant response; managed by dose increase, switching drugs, or augmenting with other medications or therapy."
    },
    {
      "id": "PHARMA_016",
      "difficulty": "medium",
      "type": "basic",
      "question": "When do SSRIs achieve their full therapeutic effects?",
      "options": {
        "A": "Immediately upon administration",
        "B": "Within 1-2 weeks of starting",
        "C": "After 6-8 weeks of treatment",
        "D": "After 3-4 months of treatment"
      },
      "correct_answer": "C",
      "kn_id": "KN3",
      "explanation": "Antidepressants have delayed onset with initial effects around 2-4 weeks and full therapeutic effects not achieved until 6-8 weeks."
    },
    {
      "id": "PHARMA_017",
      "difficulty": "medium",
      "type": "basic",
      "question": "Why are MAOIs used for treatment-resistant depression?",
      "options": {
        "A": "Increase dopamine and serotonin levels",
        "B": "Fewer side effects than other drugs",
        "C": "Inhibit monoamine oxidase enzyme",
        "D": "Can be combined with other antidepressants"
      },
      "correct_answer": "C",
      "kn_id": "KN3",
      "explanation": "MAOIs increase levels of norepinephrine, serotonin, and dopamine by inhibiting monoamine oxidase enzyme activity; useful for treatment-resistant and atypical depression."
    },
    {
      "id": "PHARMA_018",
      "difficulty": "hard",
      "type": "difficult",
      "question": "What is hypertensive crisis and which foods/drugs trigger it with MAOIs?",
      "options": {
        "A": "Dangerously high blood pressure from tyramine",
        "B": "Rapid heart rate from amphetamines only",
        "C": "Overdose symptoms from double dosing",
        "D": "Withdrawal symptoms from cessation"
      },
      "correct_answer": "A",
      "kn_id": "KN2",
      "explanation": "MAOIs can cause hypertensive crisis when combined with foods containing tyramine (aged cheese, soy, red wine) or drugs (amphetamines, antihistamines), causing severe headache and cardiovascular symptoms."
    },
    {
      "id": "PHARMA_019",
      "difficulty": "medium",
      "type": "distinction",
      "question": "How do tertiary and secondary amine TCAs differ?",
      "options": {
        "A": "Tertiary affect serotonin; secondary affect dopamine",
        "B": "Tertiary more potent on serotonin; secondary more on norepinephrine",
        "C": "Secondary TCAs work faster",
        "D": "Tertiary TCAs are safer in overdose"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Tertiary amines inhibit serotonin reuptake preferentially; secondary amines are more potent at inhibiting norepinephrine reuptake and have fewer side effects."
    },
    {
      "id": "PHARMA_020",
      "difficulty": "easy",
      "type": "basic",
      "question": "What is discontinuation syndrome and when does it occur?",
      "options": {
        "A": "Permanent loss of drug effectiveness",
        "B": "Withdrawal-like symptoms from abrupt cessation",
        "C": "Long-term accumulation of medication",
        "D": "Allergic reaction to the drug"
      },
      "correct_answer": "B",
      "kn_id": "KN2",
      "explanation": "Discontinuation syndrome occurs when SSRIs or MAOIs are abruptly stopped, causing headaches, dizziness, mood lability, sleep disturbances, and flu-like symptoms."
    }
  ]
}
